Evidence map›Paper›PMID 28004181›Full record

ArticleLung2017

The Effect of Aerosol Saline on Laboratory-Induced Dyspnea.

C R O'Donnell, R W Lansing, R M Schwartzstein, Robert Banzett

Open access · greenAbstract read
In one paragraph

Article in Lung, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

C R O'DonnellDivision of Pulmonary, Critical Care & Sleep Medicine, Beth Israel Deaconess Medical Center, Rm KB26, Boston, MA, 02215, USA.
R W LansingDivision of Pulmonary, Critical Care & Sleep Medicine, Beth Israel Deaconess Medical Center, Rm KB26, Boston, MA, 02215, USA.
R M SchwartzsteinDivision of Pulmonary, Critical Care & Sleep Medicine, Beth Israel Deaconess Medical Center, Rm KB26, Boston, MA, 02215, USA.
Robert BanzettDivision of Pulmonary, Critical Care & Sleep Medicine, Beth Israel Deaconess Medical Center, Rm KB26, Boston, MA, 02215, USA. rbanzett@bidmc.harvard.edu.ORCID 0000-0002-3626-5735
Beth Israel Deaconess Medical Center · US

Funding

Quantifying a Vital Symptom: Large-scale Inpatient Dyspnea MeasurementR01NR010006 · NINR · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BANZETT, ROBERT B · 2007 to 2017
$4.0M
AEROSOL FUROSEMIDE FOR DYSPNEA RELIEF: LABORATORY AND CLINICAL STUDIESR01NR012009 · NINR · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BANZETT, ROBERT B · 2011 to 2015
$2.3M
NINR NIH HHS R01 NR010006NINR NIH HHS R01 NR012009
6 · The paper itself

Abstract

purposeIn the 'placebo arm' of a recent study, we found that aerosol saline (sham treatment) produced substantial relief of laboratory-induced dyspnea (Breathing discomfort-BD) in nearly half the subjects. The sham intervention included a physiological change, and instructions to subjects could have produced expectation of dyspnea relief. In the present study, we attempted to discover whether the response to sham aerosol was driven by behavioral or physiological aspects of the intervention.

methodsDyspnea (air hunger) was evoked by constraining tidal volume during graded hypercapnia. We measured [Formula: see text] versus BD relationship before and after aerosol saline. To minimize subjects' expectations of dyspnea relief, participants were clearly instructed that we would only deliver saline aerosol. In Protocol 1, we delivered aerosol saline with a ventilator (mimicking our prior study); in Protocol 2, we delivered aerosol without a ventilator.

resultsAdministration of aerosol saline had little effect on BD in this group of subjects with one exception: one subject experienced appreciable reduction in BD in Protocol 1. This treatment effect was less in Protocol 2. The two most likely explanations are (a) that procedures surrounding ventilator administration of aerosol produced a psychological placebo treatment effect even though the subject knew a drug was not given; (b) there were behavioral changes in breathing undetected by our measurements of respiratory flow and volume that altered the subjects comfort.

conclusionWhen the expectation of treatment effect is minimized, a significant reduction in dyspnea in response to saline placebo is uncommon but not impossible.

Indexed as

Administration, InhalationAdultAerosolsDyspneaFemaleHumansMalePlacebo EffectSodium ChlorideVentilators, MechanicalAerosolsSodium ChlorideAerosol treatmentDyspneaPlaceboSymptom management

Identifiers

PMID28004181
PMCPMC5394930
OpenAlexW2561392823

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.